Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein

Abstract

We investigated the expression of the PLZF gene in purified human hematopoietic progenitors induced to unilineage erythroid, granulocytic or megakaryocytic differentiation and maturation in serum-free culture. PLZF is expressed in quiescent progenitors: the expression level progressively rises through megakaryocytic development, whereas it gradually declines in erythroid and granulopoietic culture. To investigate the role of PLZF in megakaryopoiesis, we transduced the PLZF gene into the erythro-megakaryocytic TF1 cell line. PLZF overexpression upmodulates the megakaryocytic specific markers (CD42a, CD42b, CD61, PF4) and induces the thrombopoietin receptor (TpoR). The proximal promoter of the TpoR gene is activated in PLZF-expressing TF1 cells: in this promoter region, a PLZF DNA-binding site was identified by deletion constructs studies. Interestingly, PLZF and GATA1 proteins coimmunoprecipitate in PLZF-expressing TF1 cells: enforced expression of both PLZF and GATA1 in TF1 cells results in increased upregulation of megakaryocytic markers, as compared to exogenous PLZF or GATA1 alone, suggesting a functional role for the PLZF/GATA1 complex. Our data indicate that PLZF plays a significant stimulatory role in megakaryocytic development, seemingly mediated in part by induction of TpoR expression at transcriptional level. This stimulatory effect is potentiated by physical interaction of PLZF and GATA1, which are possibly assembled in a multiprotein transcriptional complex.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Albagli O, Lantoine D, Quief S, Quignon F, Englert C, Kerckaert JP, Montarras D, Pinset C, Lindon C . 1999 Oncogene 18: 5063–5075

  • Ahmad KF, Engel CK, Prive GG . 1998 Proc. Natl. Acad. Sci USA 95: 12123–12128

  • Ball H, Melnick A, Shaknovich R, Kohanski R, Licht JD . 1999 Nucleic Acids Res. 27: 4106–4113

  • Bardwell VJ, Treisman R . 1994 Genes Dev. 8: 1664–1677

  • Barna M, Hawe N, Niswander L, Pandolfi PP . 2000 Nature Genetics 25: 166–172

  • Chen SJ, Zelent A, Tong JH, Yu HO, Wang ZY, Derre J, Berger R, Waxman S, Chen Z . 1993a J. Clin. Invest. 91: 2260–2267

  • Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY, Waxman S, Zelent A . 1993b EMBO J. 12: 1161–1167

  • Chen ZX, Xue Y, Zhang R, Tao R, Xia X, Li C, Wang W, Zu W, Yao X, Ling B . 1991 Blood 78: 1413–1419

  • Condorelli GL, Tocci A, Botta R, Facchiano F, Testa U, Vitelli L, Valtieri M, Croce CM, Peschle C . 1997 Mol. Cell. Biol. 17: 2954–2969

  • Cook M, Gould A, Brand N, Davies J, Strutt P, Shaknovich R, Licht J, Waxman S, Chen Z, Gluecksohn-Waelsch S, Krumlauf R, Zelent A . 1995 Proc. Natl. Acad. Sci. USA 92: 2249–2253

  • David G, Alland L, Hong SH, Wong CW, DePinho RA, Dejean A . 1998 Oncogene 16: 2549–2556

  • Davies JM, Hawa N, Kabarowski J, Huang QH, Zhu J, Brand NJ, Leprince D, Dhordain P, Cook M, Morris-Kay G, Zelent A . 1999 Oncogene 18: 365–375

  • Deveaux S, Filipe A, Lemarchandel V, Ghysdael J, Romeo PH, Mignotte V . 1996 Blood 87: 4678–4685

  • Dhordain P, Albagli O, Honore N, Guidez F, Lantoine D, Schmid M, De The H, Zelent A, Koken MHM . 2000 Oncogene 19: 6240–6250

  • Dong S, Zhu J, Reid A, Strutt P, Guidez F, Zhong HJ, Wang ZY, Licht J, Waxman S, Chomienne C, Chen Z, Zelent A, Chen SJ . 1996 Proc. Natl. Acad. Sci. USA 93: 3624–3629

  • Gabbianelli M, Sargiacomo M, Pelosi E, Testa U, Isacchi G, Peschle C . 1990 Science 249: 1561–1564

  • Godin IE, Garcia-Porrero JA, Coutinho A, Dieterlen-Lievre F, Marcos MA . 1993 Nature 364: 67–70

  • Gregory RC, Taxman DJ, Seshasayee D, Kensinger MH, Bieker JJ, Wojchowski DM . 1996 Blood 87: 1763–1801

  • Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pellici PG . 1998a Nature 391: 815–818

  • Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Grignani F, Lanfrancone L, Peschle C, Nolan GP, Pelicci PG . 1998b Cancer Res. 58: 14–19

  • Guerriero R, Testa U, Gabbianelli M, Mattia G, Montesoro E, Macioce G, Pace A, Ziegler B, Hassan HJ, Peschle C . 1995 Blood 86: 3725–3736

  • Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S, Zelent A . 1998 Blood 91: 2634–2642

  • Hawe N, Soares V, Niswander L, Cattoretti G, Pandolfi P . 1996 Blood 88: 291a, p 1151 (abstr, supp 1)

  • He LZ, Guidez F, Tribioli C, et Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP . 1998 Nat. Genet. 18: 126–135

  • Hoatlin ME, Zhi Y, Ball H, Silvey K, Melnick A, Stone S, Arai S, Hawe N, Owen G, Zelent A, Licht JD . 1999 Blood 94: 3737–3747

  • Hong SH, David G, Wong CW, Dejean A, Privalsky ML . 1997 Proc. Natl. Acad. Sci. USA 94: 9028–9033

  • Hung HL, Lau J, Kim AY, Weiss MJ, Blobel GA . 1999 Mol. Cell. Biol. 19: 3496–3505

  • Ivins S, Zelent A . 1998 Blood 92: 308a (abstr, suppl 1)

  • Koken MH, Reid A, Quignon F, Chelbi-Alix MK, Davies JM, Kabarowski JH, Zhu J, Dong S, Chen S, Chen Z, Tan CC, Licht J, Waxman S, de The H, Zelent A . 1997 Proc. Natl. Acad. Sci. USA 94: 10255–10260

  • Kotani H, Newton PB, Zhang S, Chiang YL, Otto E, Weaver L, Blaese RM, Anderson WF, McGarrity GJ . 1994 Hum. Gene Ther. 5: 19–28

  • Labbaye C, Valtieri M, Barberi T, Meccia E, Masella B, Pelosi E, Condorelli GL, Testa U, Peschle C . 1995 J. Clin. Invest. 95: 2346–2358

  • Labbaye C, Valtieri M, Grignani F, Puglisi R, Luchetti L, Masella B, Alcalay M, Testa U, Peschle C . 1999 Oncogene 18: 3529–3540

  • Li JY, English MA, Ball HJ, Yeyati PL, Waxman S, Licht JD . 1997 J. Biol. Chem. 272: 22447–22455

  • Long JJ, Leresche A, Kriwacki RW, Gottesfeld JM . 1998 Mol. Cell. Biol. 18: 1467–1476

  • Maouche L, Tournamille C, Hattab C, Boffa G, Cartron JP, Chretien S . 1991 Blood 78: 2557–2563

  • Medvinsky AL, Samoylina NL, Muller AM, Dzierzak EA . 1993 Nature 364: 64–67

  • Melnick A, Licht JD . 1999 Blood 93: 3167–3215

  • Merika M, Orkin SH . 1995 Mol. Cell. Biol. 15: 2437–2447

  • Mignotte V, Vignon I, Boucher de Crevecoeur E, Romeo PH, Lemarchandel V, Chretien S . 1994 Genomics 20: 1 5–12

  • Orkin SH . 1992 Blood 80: 575–581

  • Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V, Orkin SH, Costantini F . 1991 Nature 349: 257–260

  • Ravid K, Doi T, Beeler DL, Kuter DJ, Rosenberg RD . 1991 Mol. Cell. Biol. 11: 6116–6127

  • Reid A, Gould A, Brand N, Cook M, Strutt P, Li J, Licht J, Waxman S, Krumlauf R, Zelent A . 1995 Blood 86: 4544–4552

  • Shaknovich R, Yeyati PL, Ivins S, Melnick A, Lempert C, Waxman S, Zelent A, Licht JD . 1998 Mol. Cell. Biol. 18: 5533–5545

  • Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH . 1997 EMBO J. 16: 3965–3973

  • Tabilio A, Rosa JP, Testa U, Kieffer N, Nurden AT, Del Canizo MC, Breton-Gorius J, Vainchenker W . 1984 EMBO J. 3: 453–459

  • Takahashi S, Romeno T, Suwabe N, Yoh K, Nakajima O, Nishimura S, Kuroha T, Nagasawa T, Yamamoto M . 1998 Blood 92: 434–442

  • Testa U, Fossati C, Samoggia P, Masciulli R, Mariani G, Hassan HJ, Sposi NM, Guerriero R, Rosato V, Gabbianelli M, Pelosi E, Valtieri M, Peschle C . 1996 Blood 88: 3391–3406

  • Tsang AH, Neufeld TP, Kvan E, Rubin GM . 1997 Cell 90: 459–467

  • Valtieri M, Schiro R, Chelucci C, Masella B, Testa U, Casella I, Montesoro E, Mariani G, Hassan HJ, Peschle C . 1994 Cancer Res. 54: 4398–4404

  • Vignon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M . 1992 Proc. Natl. Acad. Sci. USA 89: 5640–5644

  • Vyas P, Ault K, Jackson CW, Orkin SH, Shivdasani RA . 1999 Blood 93: 2867–2875

  • Wadman IA, Osada H, Grutz GG, Agulnick AD, Westphal H, Forster A, Rabbitts TH . 1997 EMBO J. 16: 3145–3157

  • Ward JO, McConnell MJ, Carlile GW, Pandolfi PP, Licht JD, Freedman LP . 2001 Blood 98: 3290–3300

  • Wong CW, Privalsky ML . 1998 J. Biol. Chem. 273: 27695–27702

  • Yamaguchi Y, Zon LI, Ackerman SJ, Yamamoto M, Suda T . 1998 Blood 91: 450–457

  • Yang E, Korsmeyer SJ . 1996 Blood 88: 386–401

  • Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxman S, Nason-Burchenal K, Dmitrovsky E, Zelent A, Licht JD . 1999 Oncogene 18: 925–934

  • Zhang P, Behre G, Pan J, Iwana A, Wara-Aswapati N, Radomska HS, Auron PE, Tenen DG . 1999a Proc. Natl. Acad. Sci. USA 96: 8705–8710

  • Zhang T, Xiong H, Kan LX, Zhang CK, Jiao XF, Fu G, Zhang QH, Lu L, Tong JH, Gu BW, Yu M, Liu JX, Licht J, Waxman S, Zelent A, Chen E, Chen SJ . 1999b Proc. Natl. Acad. Sci. USA 96: 11422–11427

  • Zimmet J, Ravid K . 2000 Exp. Hematol. 28: 3–16

Download references

Acknowledgements

We thank M Blasi and M Fontana for editorial assistance and A Zito and G Loreto for graphics. This work was partially supported by NIH grant CA 59936 to JD Licht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Catherine Labbaye.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Labbaye, C., Quaranta, M., Pagliuca, A. et al. PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein. Oncogene 21, 6669–6679 (2002). https://doi.org/10.1038/sj.onc.1205884

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205884

Keywords

This article is cited by

Search

Quick links